Great Strides
Corporate Sponsors

    Outstanding Corporate Partner
   American Airlines is an Outstanding Corporate Partner of the CF Foundation and a national sponsor of GREAT STRIDES.

       National Corporate Partner
     Solvay Cares is a National Corporate Partner of the Cystic Fibrosis Foundation and a sponsor of GREAT STRIDES.
Click To Donate  Join My Walk Team  Send Page To Others Print Page

Welcome to Bethany's GREAT STRIDES Home Page!

Personal Image Hey everyone! Thank you to all who donated and/or participated in the walk in Nashville, TN last year. It was a beautiful day and a very successful fundraiser! It makes a huge impact on many lives so thank you for donating to the Cystic Fibrosis Foundation!!!!! This past year we had a very important announcement regarding the continued development of VX-770. It would not be possible without your commitment and focus on our shared goals. If you are new to this organization I wrote a little bit about it below (and also this past year's exciting news):

GREAT STRIDES is the Cystic Fibrosis Foundation's largest and most successful national fund-raising event. This year, I'm walking in the Great Strides Walk in Nashville, TN at the Nashville Zoo on May 16, 2009. Please help me meet my fund-raising goal of $2,000 by sponsoring me. Your generous gift will be used efficiently and effectively, as nearly 90 cents of every dollar of revenue raised is available for investment in vital CF programs to support research, care and education.

THIS PAST YEAR brought some remarkable news regarding the development of VX-770, a promising therapy being developed and tested by Vertex Pharmaceuticals with support from the CF Foundation.On October 20, 2008 Vertex announced positive results from the second part of a Phase 2a clinical trial of VX-770. Patients who took the investigational drug over a longer 28-day period had significant improvement in lung function, sweat chloride and nasal potential difference -- important indicators of CF. These results reinforce the positive results reported last March from the first part of the trial and validate that with oral "CFTR modulators" we are on the right path to developing new therapies that treat the basic defect in CF. Based on this positive data, Vertex Pharmaceuticals plans to work with regulatory agencies, including the U.S. Food and Drug Administration, to move VX-770 forward in the approval process. The company is targeting the first half of 2009 to initiate a pivotal trial that could lead to drug approval. This would not have been possible without your support!!!!!

Making a donation is easy and secure! Just click the "Click to Donate" button on this page to go to make a donation that will be credited to my team. Any amount you can donate is greatly appreciated! I understand that we are all facing difficult economic times, but we cannot allow this very promising momentum to slow down. We are on the cusp of a major breakthrough with our drug development pipeline.

Together we will continue to add tomorrows everyday!

xoxo, Bethany

ABOUT CF: Cystic fibrosis (CF) is a devastating genetic disease that affects tens of thousands of children and young adults in the United States. Research and care supported by the Cystic Fibrosis Foundation is making a huge difference in extending the quality of life for those with CF. However, we continue to lose precious lives to CF every day. That's why your help is needed now more than ever to ensure that a cure is found sooner - rather than later. To learn more about CF and the CF Foundation, visit www.cff.org

Below is a list of donors who have donated to support me. Thanks to everyone for your support!
Be the first one! Click Here to donate.
Team fundraising goal: $2,000.00
Money raised to date:  $0.00
0% 0%
Click To Donate  Join My Walk Team  Send Page To Others